DoctorsSahar Bedrood, MD, PhD

Sahar Bedrood, MD, PhD

Title: Assistant Professor of Clinical Ophthalmology

Department: Ophthalmology

Clinical Specialty: Glaucoma

Treatment Expertise: Glaucoma

Certification: American Board of Ophthalmology

Languages: English, Farsi, Spanish

Location: Los Angeles, Pasadena

Biography and Education


Sahar Bedrood, MD, PhD, is an assistant professor of ophthalmology at USC Roski Eye Institute. Her professional interests include studying the structural characteristics of the optic nerve lamina cribrosa in glaucoma patients, understanding the ways in which pseudoexfoliation causes glaucoma and taking a leadership role in medical and surgical education.

Dr. Bedrood received her undergraduate degree in biochemistry and chemistry at University of California Los Angeles. She then completed a combined MD/PhD program at the Keck School of Medicine of USC. She received her PhD in biochemistry and molecular biology for her work on structural features and drug modifiers of misfolded proteins such as amyloid proteins involved in neurodegenerative diseases and diabetes mellitus. Dr. Bedrood completed her internal medicine internship at Huntington Memorial Hospital in Pasadena, California. She completed her residency in ophthalmology at the USC Roski Eye Institute and her fellowship in glaucoma as a Society of Heed Fellow at the Wilmer Eye Institute at Johns Hopkins University in Baltimore. Additionally, Bedrood has been honored with multiple awards throughout her training for both her leadership and her research endeavors, including the Order of the Areté, the PEO Scholar Award and the Remarkable Women of USC Award. She is a member of several national and international professional societies including American Academy of Ophthalmology and Association for Research in Vision and Ophthalmology.


  • MD/PhD, Keck School of Medicine, University of Southern California, 2011
  • BS, University of California Los Angeles, 2003


  • Huntington Memorial Hospital, Internal Medicine, 2012


  • LAC+USC Medical Center, Ophthalmology, 2015


  • Wilmer Eye Institute, Johns Hopkins Hospital, Glaucoma, 2016


Professional society memberships:

  • American Glaucoma Society
  • American Society of Cataract and Refractive Surgery
  • Los Angeles Society of Ophthalmology
  • Society of Heed Fellows


  • Society of Heed Fellows Fellowship Award, 2015-2016
  • National Eye Institute 2011 ARVO Award, 2011
  • Department of Ophthalmology, University of Southern California ARVO Basic Science Award, 2011
  • P.E.O. Scholar Award- international award for women pursuing doctoral degrees, 2009
  • Order of the Areté, 2009
  • Remarkable Women of USC Award, 2008


  1. Quigley H, Arora K, Idrees S, Solano F, Bedrood S, Lee C, Jefferys J, Nguyen T. Biomechanical Responses of Lamina Cribrosa to Intraocular Pressure Change Assessed by Optical Coherence Tomography in Glaucoma Eyes. Invest Ophthalmol Vis Sci. 2017 May;58(5):2566-77.
  2. Okada AK, Teranishi K, Isas JM, Bedrood S, Chow RH, Langen R. Diabetic Risk Factors Promote Islet Amyloid Polypeptide Misfolding by a Common, Membrane-Mediated Mechanism. Sci Rep. 2016;6:31094.
  3. Bedrood S, Li Y, Isas JM, Hegde BG, Baxa U, Haworth IS, Langen R. Fibril Structure of Human Islet Amyloid Polypeptide. J Biol Chem. 2012 Feb 17;287(8):5235-41
  4. Daval M, Bedrood S, Gurlo T, Huang CJ, Costes S, Butler PC, Langen R. The Effect of Curcumin on Human Islet Amyloid Polypeptide Misfolding and Toxicity. Amyloid. 2010 Sep;17(3-4):118-28
  5. Bedrood S, Jayasinghe S, Sieburth D, Chen M, Erbel S, Butler PC, Langen R, Ritzel RA. Annexin A5 Directly Interacts with Amyloidogenic Proteins and Reduces Their Toxicity. Biochemistry. 2009 Nov 10;48(44):10568-76
  6. Ignarro LJ, Sisodia M, Trinh K, Bedrood S, Wu G, Wei LH, Buga GM. Nebivolol Inhibits Vascular Smooth Muscle Cell Proliferation by Mechanisms Involving Nitric Oxide but Not Cyclic Gmp. Nitric Oxide. 2002 Sep;7(2):83-90